cytarabine has been researched along with propranolol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chadwick, DP; Herman, EH | 1 |
| Barka, T; Gresik, EW; vad der Noen, H | 1 |
| Galbraith, WM; Mellett, LB; Schneyer, CA | 1 |
| Galbraith, WM; Schneyer, CA | 1 |
| Schneyer, CA; Yu, JH | 1 |
| Dabadghao, S; Dennison, D; Srivastava, A | 1 |
1 review(s) available for cytarabine and propranolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for cytarabine and propranolol
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Some cardiovascular effects of cyclocytidine.
Topics: Ancitabine; Animals; Blood Pressure; Cytarabine; Dogs; Haplorhini; Heart; Heart Rate; Male; Myocardial Contraction; Propranolol; Reserpine; Stimulation, Chemical | 1976 |
Stimulation of secretion of epidermal growth factor and amylase of cyclocytidine.
Topics: Adrenergic alpha-Antagonists; Amylases; Ancitabine; Animals; Cytarabine; Drug Antagonism; Growth Substances; Male; Mice; Propranolol; Skin; Submandibular Gland; Time Factors | 1978 |
Unexpected beta adrenergic effects of the antitumor agent, cyclocytidine, on rat salivary glands.
Topics: Adrenergic beta-Agonists; Amylases; Animals; Antineoplastic Agents; Atropine; Cardiomegaly; Cytarabine; Denervation; DNA; Female; Ganglia, Autonomic; Hypertrophy; Myocardium; Organ Size; Parotid Gland; Phenoxybenzamine; Potassium; Propranolol; Rats; RNA; Saliva; Salivary Gland Diseases; Salivary Glands; Secretory Rate; Submandibular Gland | 1975 |
Inhibition of cyclocytidine-induced enlargement of parotid and heart by propranolol or sympathectomy.
Topics: Animals; Antineoplastic Agents; Cytarabine; Female; Heart; Mice; Organ Size; Parotid Gland; Propranolol; Rats; Sympathectomy | 1975 |
Calcium concentration of saliva and salivary glands of rat after cyclocytidine.
Topics: Ancitabine; Animals; Calcium; Cytarabine; Female; Norepinephrine; Organ Size; Propranolol; Rats; Reserpine; Saliva; Salivary Glands; Time Factors | 1984 |
Bilateral submandibular salivary gland enlargement during chemotherapy for acute myeloid leukaemia--beneficial effect of propranolol.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Propranolol; Submandibular Gland | 1996 |